TTK HEALTHCARE
Back to Cashflow Statement
|
TTK HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-18 Cr | ₹-22 Cr | ₹-12 Cr | ₹-10 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of TTK HEALTHCARE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹-12 Cr |
| Mar2022 | ₹-10 Cr |
| Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of TTK HEALTHCARE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹-12 Cr | Negative | |
| Mar2022 | ₹-10 Cr | Negative | |
| Mar2021 | ₹-17 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TTK HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TTK HEALTHCARE | ₹1,074.2 Cr | -6.2% | -16.9% | -29.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
TTK HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TTK HEALTHCARE | -6.2% |
-16.9% |
-29.9% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses